MICHAEL W ROGERS Insider Trading $ACOR ACORDA THERAPEUTICS INC
Get free email notifications about insider trading for MICHAEL W ROGERS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL W ROGERS. MICHAEL W ROGERS is Executive Vice President in Endo Pharmaceuticals Solutions Inc. ($IDEV) and Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Chief Financial Officer in ACORDA THERAPEUTICS INC ($ACOR) and in EyePoint Pharmaceuticals, Inc. ($EYPT) and Director in pSivida Corp. ($PSDV) and Chief Financial Officer in Aerpio Pharmaceuticals, Inc. ($ZETAII) and Director in Aravive, Inc. ($ARAV) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA).
MICHAEL W ROGERS in ACORDA THERAPEUTICS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MICHAEL W ROGERS: Chief Financial Officer
Holdings: 40,713 shares
Current Value: $863,116
Latest Transaction: May 13 2016
$ACOR Market Capitalization: $941.09M
$ACOR Previous Close: $21.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL W ROGERS in ACORDA THERAPEUTICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACOR, ARPO, AKBA, ARAV, IDEV, EYPT, KERX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2016 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 26.40 | 20,000 | 528,000 | 20,000 | |
| Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 35.53 | 26,796 | 952,062 | 26,796 | |
| Dec 03 2015 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Sell | S | 38.06 | 964 | 36,689 | 40,713 | 41.7 K to 40.7 K (-2.31 %) |
| Oct 09 2015 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Sell | S | 30.45 | 4,433 | 134,963 | 41,677 | 46.1 K to 41.7 K (-9.61 %) |
| Oct 09 2015 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Sell | S | 29.52 | 1,267 | 37,396 | 46,110 | 47.4 K to 46.1 K (-2.67 %) |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 35.74 | 33,278 | 1,189,356 | 33,278 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Grant | A | 0.00 | 5,872 | 0 | 47,377 | 41.5 K to 47.4 K (+14.15 %) |
Page: 1